blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2664337

EP2664337 - Amniotic membrane preparations and purified compositions and methods of use [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 24.04.2024
FormerThe patent has been granted
Status updated on  12.07.2019
FormerGrant of patent is intended
Status updated on  24.02.2019
FormerExamination is in progress
Status updated on  18.11.2016
Most recent event   Tooltip16.07.2021Lapse of the patent in a contracting state
New state(s): HU		published on 18.08.2021  [2021/33]
Applicant(s)For all designated states
TissueTech, Inc.
7000 S.W. 97th Avenue, Suite 212 Miami
Florida 33173 / US
[2019/33]
Former [2013/47]For all designated states
TissueTech, Inc.
7000 S.W. 97th Avenue, Suite 212 Miami
Florida 33173 / US
Inventor(s)01 / HE, Hua
Tissue Tech, Inc.
7000 S.W. 97th Avenue, Suite 212
Miami, FL 33173 / US
02 / LI, Wei
Tissue Tech, Inc.
7000 S.W. 97th Avenue, Suite 212
Miami, FL 33173 / US
03 / TSENG, Scheffer C. G.
Tissue Tech, Inc.
7000 S.W. 97th Avenue, Suite 212
Miami, FL 33173 / US
 [2019/33]
Former [2013/47]01 / He, Hua
7570 SW 82 St. F210
Miami, FL 33143 / US
02 / Li, Wei
Songbai Road Jixin Yayuan
Building A-603
Songgang Town Baoan District Shenzhen Guangdong 518105 / CN
03 / Tseng, Scheffer C. G.
10000 SW 63rd Place
Pinecrest, FL 33156 / US
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2019/33]HGF Limited
8th Floor
140 London Wall
London EC2Y 5DN / GB
Former [2013/47]Williams, Richard Andrew Norman
Harrison Goddard Foote LLP
140 London Wall
London EC2Y 5DN / GB
Application number, filing date13163155.827.09.2006
[2013/47]
Priority number, dateUS20050720760P27.09.2005         Original published format: US 720760 P
[2013/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2664337
Date:20.11.2013
Language:EN
[2013/47]
Type: B1 Patent specification 
No.:EP2664337
Date:14.08.2019
Language:EN
[2019/33]
Search report(s)(Supplementary) European search report - dispatched on:EP21.10.2013
ClassificationIPC:A61K35/12, C07K14/47, C07K14/78, A61K35/50, A61K38/17, A61K38/39, A61K38/48, A61K35/48, C07K14/81
[2013/47]
CPC:
A61K35/50 (EP,US); A61K31/738 (EP,US); A61K35/48 (EP,US);
A61K38/1709 (EP,US); A61K38/39 (EP,US); A61K38/4886 (EP,US);
A61K8/982 (US); A61K9/0014 (US); A61K9/0048 (US);
A61K9/0053 (US); A61K9/06 (US); A61K9/08 (US);
A61K9/19 (US); A61L15/40 (US); A61L15/44 (US);
A61P17/00 (EP); A61P17/02 (EP); A61P19/02 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61Q19/00 (US);
C07K14/4702 (EP,US); C07K14/4718 (EP,US); C07K14/78 (EP,US);
C07K14/8114 (EP,US); A61K2800/74 (US); A61L2300/412 (US);
A61L2300/64 (US) (-)
C-Set:
A61K38/1709, A61K2300/00 (EP,US);
A61K38/39, A61K2300/00 (US,EP);
A61K38/4886, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2019/33]
Former [2013/47]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Amnion-Zubereitungen und gereinigte Zusammensetzungen und Anwendungsverfahren[2013/47]
English:Amniotic membrane preparations and purified compositions and methods of use[2013/47]
French:Preparations de membrane amniotique et compositions purifiees, et procedes d'utilisation[2013/47]
Examination procedure20.05.2014Amendment by applicant (claims and/or description)
20.05.2014Examination requested  [2014/26]
13.07.2015Despatch of a communication from the examining division (Time limit: M04)
23.12.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
13.01.2016Reply to a communication from the examining division
08.11.2016Despatch of a communication from the examining division (Time limit: M04)
08.03.2017Reply to a communication from the examining division
11.07.2017Despatch of a communication from the examining division (Time limit: M06)
29.11.2017Reply to a communication from the examining division
27.02.2018Despatch of a communication from the examining division (Time limit: M04)
09.07.2018Reply to a communication from the examining division
25.02.2019Communication of intention to grant the patent
27.06.2019Fee for grant paid
27.06.2019Fee for publishing/printing paid
27.06.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06804232.4  / EP1933852
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060804232) is  04.04.2011
Opposition(s)03.06.2020No opposition filed within time limit [2020/33]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
13.01.2016Request for further processing filed
13.01.2016Full payment received (date of receipt of payment)
Request granted
27.01.2016Decision despatched
Fees paidRenewal fee
26.06.2013Renewal fee patent year 03
26.06.2013Renewal fee patent year 04
26.06.2013Renewal fee patent year 05
26.06.2013Renewal fee patent year 06
26.06.2013Renewal fee patent year 07
12.09.2013Renewal fee patent year 08
12.09.2014Renewal fee patent year 09
28.09.2015Renewal fee patent year 10
27.09.2016Renewal fee patent year 11
27.09.2017Renewal fee patent year 12
27.09.2018Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.09.2006
AT14.08.2019
CY14.08.2019
CZ14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
MC14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
SI14.08.2019
SK14.08.2019
TR14.08.2019
IE27.09.2019
LU27.09.2019
BE30.09.2019
CH30.09.2019
LI30.09.2019
FR14.10.2019
BG14.11.2019
GB14.11.2019
GR15.11.2019
IS14.12.2019
PT16.12.2019
DE01.04.2020
[2021/33]
Former [2021/26]AT14.08.2019
CY14.08.2019
CZ14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
MC14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
SI14.08.2019
SK14.08.2019
TR14.08.2019
IE27.09.2019
LU27.09.2019
BE30.09.2019
CH30.09.2019
LI30.09.2019
FR14.10.2019
BG14.11.2019
GB14.11.2019
GR15.11.2019
IS14.12.2019
PT16.12.2019
DE01.04.2020
Former [2020/48]AT14.08.2019
CZ14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
MC14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
SI14.08.2019
SK14.08.2019
TR14.08.2019
IE27.09.2019
LU27.09.2019
BE30.09.2019
CH30.09.2019
LI30.09.2019
FR14.10.2019
BG14.11.2019
GB14.11.2019
GR15.11.2019
IS14.12.2019
PT16.12.2019
DE01.04.2020
Former [2020/37]AT14.08.2019
CZ14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
MC14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
SI14.08.2019
SK14.08.2019
TR14.08.2019
IE27.09.2019
LU27.09.2019
BE30.09.2019
CH30.09.2019
LI30.09.2019
BG14.11.2019
GR15.11.2019
IS14.12.2019
PT16.12.2019
DE01.04.2020
Former [2020/36]AT14.08.2019
CZ14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
MC14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
SK14.08.2019
TR14.08.2019
IE27.09.2019
LU27.09.2019
CH30.09.2019
LI30.09.2019
BG14.11.2019
GR15.11.2019
IS14.12.2019
PT16.12.2019
DE01.04.2020
Former [2020/35]AT14.08.2019
CZ14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
MC14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
SK14.08.2019
TR14.08.2019
LU27.09.2019
CH30.09.2019
LI30.09.2019
BG14.11.2019
GR15.11.2019
PT16.12.2019
IS24.02.2020
DE01.04.2020
Former [2020/34]AT14.08.2019
CZ14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
MC14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
SK14.08.2019
TR14.08.2019
CH30.09.2019
LI30.09.2019
BG14.11.2019
GR15.11.2019
PT16.12.2019
IS24.02.2020
DE01.04.2020
Former [2020/27]AT14.08.2019
CZ14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
MC14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
SK14.08.2019
TR14.08.2019
BG14.11.2019
GR15.11.2019
PT16.12.2019
IS24.02.2020
Former [2020/25]AT14.08.2019
CZ14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
SK14.08.2019
TR14.08.2019
BG14.11.2019
GR15.11.2019
PT16.12.2019
IS24.02.2020
Former [2020/24]AT14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
TR14.08.2019
BG14.11.2019
GR15.11.2019
PT16.12.2019
IS24.02.2020
Former [2020/23]AT14.08.2019
DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
IT14.08.2019
LT14.08.2019
LV14.08.2019
NL14.08.2019
PL14.08.2019
RO14.08.2019
SE14.08.2019
TR14.08.2019
BG14.11.2019
GR15.11.2019
IS14.12.2019
PT16.12.2019
Former [2020/22]DK14.08.2019
EE14.08.2019
ES14.08.2019
FI14.08.2019
LT14.08.2019
LV14.08.2019
NL14.08.2019
SE14.08.2019
TR14.08.2019
BG14.11.2019
GR15.11.2019
IS14.12.2019
PT16.12.2019
Former [2020/17]ES14.08.2019
FI14.08.2019
LT14.08.2019
LV14.08.2019
NL14.08.2019
SE14.08.2019
TR14.08.2019
BG14.11.2019
GR15.11.2019
IS14.12.2019
PT16.12.2019
Former [2020/12]ES14.08.2019
FI14.08.2019
LT14.08.2019
LV14.08.2019
NL14.08.2019
SE14.08.2019
BG14.11.2019
GR15.11.2019
IS14.12.2019
PT16.12.2019
Former [2020/10]FI14.08.2019
LT14.08.2019
NL14.08.2019
SE14.08.2019
BG14.11.2019
PT16.12.2019
Former [2020/09]FI14.08.2019
LT14.08.2019
NL14.08.2019
Former [2020/08]LT14.08.2019
Documents cited:Search[A]US5192744  (BOUCK NOEL P [US], et al) [A] 1-15 * abstract * * claim 1 * * column 5, line 65 - column 6, line 9 *;
 [A]US6152142  (TSENG SCHEFFER C G [US]) [A] 1-15 * column 2, line 39 - line 42 *;
 [X]WO03077794  (TISSUETECH INC [US], et al) [X] 1-15 * paragraph [0032] * * paragraph [0056] * * paragraph [0113] * * paragraph [0114] *;
 [X]US2004057938  (GHINELLI EMILIANO [US]) [X] 1-15 * abstract * * claim 14 * * paragraph [0007] *;
 [A]WO2005060988  (DEFIANTE FARMACEUTICA LDA [PT], et al) [A] 1-15 * abstract ** claims 7-12 *;
 [XP]WO2006094247  (TISSUETECH INC [US], et al) [XP] 1-15 * abstract * * paragraph [0048] * * claim 15 *;
 [XD]  - NA ET AL, "Analysis of human amniotic membrane components as proteinase inhibitors for development of therapeutic agent for recalcitrant keratitis", PLACENTA, W.B. SAUNDERS, GB, (19990101), vol. 20, doi:10.1016/S0143-4004(99)80034-4, ISSN 0143-4004, pages 453 - 466, XP005419091 [XD] 1-15 * page 454 * * page 463 - page 464 *

DOI:   http://dx.doi.org/10.1016/S0143-4004(99)80034-4
 [AP]  - DAY ET AL, "Hyaluronan cross-linking: a protective mechanism in inflammation?", TRENDS IN IMMUNOLOGY, ELSEVIER, RAHWAY, NJ, US LNKD- DOI:10.1016/J.IT.2005.09.009, (20051201), vol. 26, no. 12, ISSN 1471-4906, pages 637 - 643, XP005172384 [AP] 1-15 * page 640 *

DOI:   http://dx.doi.org/10.1016/j.it.2005.09.009
Examination   - K. Temma ET AL, "Effects of 4-hydroxy-2-nonenal, a marker of oxidative stress, on the cyclooxygenase-2 of human placenta in chorioamnionitis", Molecular Human Reproduction, (20040101), vol. 10, no. 3, doi:10.1093/molehr/gah030, pages 167 - 171, XP055315804

DOI:   http://dx.doi.org/10.1093/molehr/gah030
    - N. Ahmed, "Expression and localization of  v 6 integrin in extraplacental fetal membranes: possible role in human parturition", MOLECULAR HUMAN REPRODUCTION., GB - BE, (20040129), vol. 10, no. 3, doi:10.1093/molehr/gah025, ISSN 1360-9947, pages 173 - 179, XP055315815

DOI:   http://dx.doi.org/10.1093/molehr/gah025
by applicantUS3598122
 US3598123
 US3710795
 US3731683
 US3742951
 US3814097
 US3921636
 US3972995
 US3993072
 US3993073
 US3996934
 US4031894
 US4060084
 US4069307
 US4077407
 US4201211
 US4230105
 US4292299
 US4292303
 US4327725
 US4476116
 US4624848
 US4871549
 US4968509
 US5011692
 US5017381
 US5033252
 US5052558
 US5116817
 US5229135
 US5260068
 US5260069
 US5323907
 US5336168
 US5456923
 US5461140
 US5508040
 US5516527
 US5567441
 US5622721
 US5665378
 US5686105
 US5700410
 US5837280
 US5837284
 US5840329
 US5869090
 US5977175
 US6391452
 US6465014
 US6923983
 US6929801
 US6932983
 US6946144
    - HEILIGENHAUS ET AL., INVEST OPHTHALMOL VIS SCI., (2001), vol. 42, pages 1969 - 1974
    - LEE; TSENG, AM J OPHTHALMOL., (1997), vol. 123, pages 303 - 312
    - PRABHASAWAT ET AL., OPHTHALMOLOGY, (1997), vol. 104, pages 974 - 985
    - TSENG ET AL., ARCH OPHTHALMOL., (1998), vol. 116, pages 431 - 441
    - Molecular Cloning: A Laboratory Manual, COLD SPRING HARBOR LABORATORY PRESS, (2001), vol. 1-3
    - LIBERMAN ET AL., Pharmaceutical Dosage Forms, (1990), vol. 1, pages 209 - 214
    - SINGH ET AL., Encyclopedia of Pharmaceutical Technology, (2002), pages 751 - 753
    - BORDER ET AL., J. CLIN. INVEST., (1992), vol. 90, pages 1 - 7
    - GRANDE, PROC. SOC. EXP. BIOL. MED., (1997), vol. 214, pages 27 - 40
    - JESTER ET AL., PROG. RETIN. EYE RES., (1999), vol. 18, no. 3, pages 311 - 356
    - MAREK ET AL., MED. SCI. MONIT., (2002), vol. 8, no. 7, pages RA145 - 151
    - TSENG ET AL., OCULAR SURFACE J., (2004), vol. 2, no. 3, pages 177 - 187
    - RONNOV-JESSEN ET AL., LAB. INVEST., (1993), vol. 68, pages 696 - 707
    - VERBEEK ET AL., AM. J. PATHOL., (1994), vol. 144, pages 372 - 82
    - HALES ET AL., CURR. EYE RES., (1994), vol. 13, pages 885 - 90
    - JESTER ET AL., CORNEA, (1996), vol. 15, pages 505 - 16
    - SERINI ET AL., J. CELL. BIOL., (1998), vol. 142, pages 873 - 81
    - GRANDE, PROC. SOC. EXP. BIOL. MED., (1997), vol. 214, no. 1, pages 27 - 40
    - JESTER ET AL., PROG. RETIN. EYE. RES., (1999), vol. 18, pages 311 - 56
    - LAWRENCE, EUR. CYTOKINE NETW., (1996), vol. 7, pages 363 - 74
    - MASSAGUE ET AL., GENES AND DEVELOPMENT., (2000), vol. 14, pages 627 - 44
    - DERYNCK ET AL., BIOCHEM. BIOPHYS. ACTA., (1997), vol. 1333, pages FI05 - FI50
    - SHAHI ET AL., LANCET, (1992), vol. 339, pages 213 - 214
    - PETROLL ET AL., CURR. EYE RES., (1998), vol. 1739, pages 736 - 747
    - YAMAGUCHI ET AL., NATURE, (1990), vol. 346, no. 6281, pages 281 - 284
    - LOGAN ET AL., EXP. NEUROL., (1999), vol. 159, pages 504 - 510
    - TSENG ET AL., J CELL PHYSIOL., (1999), vol. 179, pages 325 - 335
    - LEE ET AL., CURR. EYE RES., (2000), vol. 20, no. 4, pages 325 - 334
    - FOUTUNATO ET AL., AM. J. OBSTET. GYNECOL., (1996), vol. 175, pages 1057 - 65
    - FOUTUNATO ET AL., AM. J. OBSTET. GYNECOL., (1997), vol. 177, pages 803 - 9
    - FOUTUNATO ET AL., AM. J. OBSTET. GYNECOL., (1998), vol. 179, pages 794 - 9
    - PETRAGLIA ET AL., J. CLIN. ENDOCRINOL. METAB., (1993), vol. 77, pages 542 - 8
    - RILEY ET AL., HUM. REPROD., (2000), vol. 15, pages 578 - 83
    - KEELAN ET AL., PLACENTA, (2000), vol. 31, pages 38 - 43
    - NA ET AL., TROPHOBLAST RES., (1999), vol. 13, pages 459 - 66
    - ROMERO ET AL., AM. J. OBSTET. GYNECOL., (1994), vol. 171, pages 912 - 21
    - LEE H.G.; COWMAN, M. K., "n Agarose Gel Electrophoretic Method for Analysis of Hyaluronan Molecular Weight Distribution", ANALYTICAL BIOCHEMISTRY, (1994), vol. 219, pages 278 - 287
    - NOMA ET AL., GROWTH FACTORS, (1991), vol. 4, pages 247 - 255
    - BAE ET AL., J BIOL CHEM., (1995), vol. 270, pages 29460 - 29468
    - CHEN ET AL., J IMMUNOL., (2001), vol. 167, pages 1297 - 1305
    - HE ET AL., PROC NATL ACAD SCI USA, (1998), vol. 95, pages 2509 - 2514
    - GABBIANI G., J PATHOL., (2003), vol. 200, pages 500 - 503
    - JESTER; PETROLL, PROG RETIN EYE RES., (1999), vol. 18, pages 311 - 356
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.